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PermeabilizationThe interaction of the tryptophan-containing variant of microcin J25, MccJ25 I13W, with phosphatidylcholine
membranes was studied by ﬂuorescence spectroscopy techniques. The peptide was able to interact with
dimiristoylphophatidylcholine and dipalmitoylphosphatidylcholine liposomes only when the membranes
were in gel phase, as was demonstrated by the blue shift of the intrinsic ﬂuorescence of MccJ25 I13W. The
binding isotherm showed a cooperative partition of the peptide toward the membrane and the binding
constant increased as the temperature decreased and the order parameter increased. No interaction with
liquid crystalline membranes was observed. Studies of dynamic quenching of the ﬂuorescence indicated that
the peptide penetrated the lipid bilayer and was located primarily in the interfacial region. Our results suggest
that MccJ25 I13W interacts with gel phase phospholipids and increases both its own afﬁnity for the bilayer
and the membrane permeability of small ions.o).
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Antimicrobial peptides are synthesized and secreted by organisms
among plant, animal and prokaryotic kingdoms and have the ability to
kill microorganisms. The mechanism of action of these peptides is
highly variable, probably because of the few features in common they
share with each other. The ability to permeabilize the plasma mem-
brane of target cells precisely is a very general feature. In order to
explain how peptides interact with and disrupt membranes, two
types of models have been proposed [1–3]. The ﬁrst model is termed
the ‘carpet’ model, where at low concentrations, peptides lay across
the surface of the membrane and, once a critical concentration is
reached, disrupt bilayers in a detergent-like manner causing the for-
mation of micelles and ultimately the disintegration of the membrane
[4]. The second type is known as the barrel-stave model and involves
the formation of discrete oligomeric pores that allow ions and other
molecules to cross the membrane [3]. Variations of this are the
‘toroidal pore’ model, whereby the pore is composed of both peptide
monomers and lipid head groups, and the aggregate model in which
the peptides and lipids form informal aggregates within the
membrane that permit ion leakage or peptide translocation across
the membrane. In the beginning, membrane permeabilization was
believed to be the sole event responsible for cell killing, although it
was actually probed for only certain peptides. Moreover, it was shown
that in some cases, depolarization of the plasma membrane alone did
not ensure viability loss of sensible cells [5], suggesting that the killingeffect mediated by antimicrobial peptides would involve multitarget
strategies.
Microcins are a miscellaneous group of low-molecular weight
peptides with antibiotic activity. They are produced by a number of
Enterobacteriaceae species, mostly Escherichia coli strains [6,7].
Although most of the microcins inhibit enzymatic pathways, mem-
brane interaction was also postulated to be part of their mechanism of
action. Microcin J25 (MccJ25) is a 21-amino acid antimicrobial pep-
tide that target certain human pathogens such as Salmonella and
Shigella [8]. The sequence is rich in hydrophobic residues and the
backbone is folded in an unusual lasso distinctive structure [9–11]:
the γ-carboxyl of the side chain of Glu8 and the N-terminal Gly1 are
covalently bonded and form an eight residue ring that is threaded by
C-terminal tail (Fig. 1). This folding is maintained by steric hindrance
between the aromatic side chains of Phe19 and Tyr20, located on each
side of the ring, and the residues of the ring [9–11]. MccJ25 exerts
antimicrobial activity by means of a dual mechanism of action [12]:
the peptide inhibits transcriptional activity by obstructing the RNA
polymerase secondary channel [13–15] and affects, independently,
the cytoplasmic membrane of Escherichia coli and Salmonella enterica
serovars [12,16,17] . In this regard, it was shown that MccJ25 causes
dissipation of the membrane electrical potential of S. enterica and
inhibition of respiratory chain enzymes such as NADH, succinate and
lactate dehydrogenase, decreasing oxygen consumption rates. The
fact that MccJ25 is a membrane-active peptide was also supported
by studies carried out on model systems, such as liposomes and
Langmuir monolayers [18,19].
In thiswork,weperformeda studyof the interaction of a tryptophan-
containing derivative of microcin J25, MccJ25 I13W, with model mem-
branes by means of ﬂuorescence spectroscopic methods. The results
Fig. 1.Microcin J25 structure obtained from PDB ﬁle 1Q71. Lateral view (A) depicts the
bulky side chains of residues Phe19 and Tyr20 and the residue Ile13 which was replaced
by tryptophan. Upper view (B) depicts the residue Ile13 and the N-terminal ring, formed
by amide bond between the sidechain of residue Glu8 and the N-terminal Gly1.
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bilayers in gel phase.
2. Materials and methods
2.1. Materials
1, 2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-
dimyristoyl-sn-glycero-3 phosphocholine (DMPC)were obtained from
Avanti Polar Lipids (Alabaster, AL). All chemicals used were of analyti-
cal grade. Potassium phosphate monobasic (KH2PO4), sodium phos-
phate dibasic (Na2HPO4), sodium chloride, Triton X-100, the spin
labels 5-doxyl stearic acid (5DS) and 16-doxyl stearic acid (16DS) and
N-acetyl-tryptophanamide (NATA) were purchased from Sigma-
Aldrich (St. Louis, MO). 3,3′-Dipropylthiadicarbocyanine iodide (DiSC3
(5)) was purchased from Molecular Probes–Invitrogen.
2.2. Mutagenesis and peptides puriﬁcation
MccJ25 and MccJ25 I13W were puriﬁed from 2-l cultures of strain
SBG231, harboring the corresponding plasmids as previously de-
scribed [19]. The purity of the peptides was evaluated by analytical
high performance chromatography in two different conﬁgurations of
a Gilson HPLC system as follows: 20 μl of a 0.1 mg ml−1 solution of
either MccJ25 or its variant, MccJ25 I13W, was loaded either on a
μBondapak C18 column (10 μm, 3.9×300 mmWaters) and eluted in a
linear gradient from 20 to 80% (v/v) methanol in triﬂuoroacetic acid
(TFA) 0.1% (v/v), or on a X-Terra MS C8 column (5 μm, 4.6×250 mm,
Waters) and eluted in a linear gradient from 0 to 60% (v/v) acetonitrile
in 0.1% (v/v) TFA. Both MccJ25 and MccJ25 I13W peptides puriﬁed in
our laboratory eluted as a single peak in these analytical chromatog-
raphy systems.
2.3. Liposome preparation
DPPC (2 mM) and DMPC (2 mM) in chloroformwere used as stock
solutions for the preparation of dried ﬁlms. The stock solutions were
aliquoted to the bottom of clean glass and the solvent was evaporated
under a gentle stream of N2 gas. Trace of the solvent was removed
under vacuum during 3 h. The dried lipid ﬁlms were hydrated by
adding the appropriate volume of buffer for a 1 mM phospholipid
dispersion and by heating and vortexing the sample about 10 °C abovethe transition temperature of each lipid. The hydrated multillamelar
suspension was then sonicated with a Branson tip sonicator for
30 min at temperatures higher than the transition temperature of the
lipids. The small unilamellar vesicles were centrifuged at 8000×g for
10 min in order to eliminate titanium particles and multilamellar
vesicles. Large unilamellar vesicles were prepared by extruding 10
times multilamellar vesicles through 100 nm polycarbonate ﬁlters
(Whatman), in a stainless steel extruder operated under high pres-
sure N2 ﬂow and heated above the main transition temperature of the
phospholipids.
2.4. Fluorescence measurements
Fluorescence was recorded on an ISS-PC1 photon-counting spec-
troﬂuorimeter. Emission and excitation slits were 1 mm width (8 nm
FWHH) and emission intensity background correctionswere performed
by subtracting the corresponding control without peptide using the
Vinci software provided by the manufacturer. A computer-controlled
stirrer device ensured constantmixing of themedium. The temperature
inside the cuvette was measured with a thermocouple and adjusted to
the desired value with a circulating water bath (Cole Parmer).
Peptide and phospholipid concentrations were always lower than
10 μM and 1 mM, respectively, in order to avoid inner ﬁlter effects
(ε278 nm, MccJ25 I13W=8714 M−1cm−1) and undesired light scattering
in the different assays. Peptide solutions and vesicles suspensions
were prepared in 10 mM KH2PO4, 100 mM Na2HPO4, 0.2 mM EDTA,
pH 7.4 (phosphate buffer).
Fluorescence quenching assays were carried out at 27 °C by adding
increasing amounts of cesium chloride from a 5 M stock solution to a
mixture containing peptide and phospholipids vesicles in a 1:200
molar ratio. Peptide and quencher ﬁnal concentration were 2.5 μM
and 400 mM, respectively. The decrease of the ﬂuorophore emission
intensity produced by the increasing volume of the mixture during
titration was negligible with respective to the cesium quenching
effect.
From the ﬂuorescence values obtained (λemission=353 nm;
λexcitation=288 nm) at different concentrations of cesium, Stern–
Volmer graphs were constructed according to the following equation:
F0
F
= 1 + KSV Q½ 
where Fo and F are the peptide ﬂuorescence intensities in the absence
and in the presence of the quencher at concentration [Q], respectively.
The Stern–Volmer constant (KSV) was calculated from the slope of the
curve and is proportional to the quencher accessibility to the peptide.
The depth of insertion of MccJ25 I13W into the lipid bilayer was
studied by quenching of the peptide intrinsic ﬂuorescence by the spin
label probes 5-DS and 16-DS. The ﬂuorescence emission at 335 nm,
excited at 288 nm, was measured after addition of successive aliquots
of methanolic stock solutions of the spin labels probes. The actual
concentration of the probes inside the hydrophobic core of the
phospholipids membranes (Q)l was calculated according to their
corresponding partition coefﬁcient (K′pQ=12570 and K′pQ=3340,
for 5-DS and 16-DS, respectively) [20].
Q½ l =
K 0pQ
1 + K 0pQγ L½ 
 !
: Q½ 
2.5. Calculation of the partition coefﬁcient of MccJ25 I13W
The peptide binding to the lipid bilayer was quantiﬁed by mea-
suring the ﬂuorescence increase at 335 nm as liposome aliquots were
added. The increase in ﬂuorescence intensity is proportional to the
amount of peptide incorporated into the vesicles [21,22], so a binding
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following equation:
I =
Iw + K
n
p :γL L½ nI max
1 + Knp :γL L½ n
where I: ﬂuorescence intensity at 335 nm; Iw: ﬂuorescence intensity
of peptide in buffer; Kp: partition coefﬁcient; [L]: lipid concentration;
Imax: ﬂuorescence intensity of the peptide in lipid phase; n: coope-
rativity parameter; γL: molar volume (0.688 L mol−1 for DPPC).
2.6. Permeability assay
Large unilamellar vesicles were loaded with Li+ by extrusion DPPC
multilamellar vesicles in 100 mM Li2SO4, 10 mM HEPES, Li 0.2 mM
EDTA, pH 7.4. Non-entrapped Li+ ions were removed by gel chroma-
tography (Sephadex G75) in a 1×10 cm column equilibrated and
eluted with 100 mM Na2SO4 10 mM HEPES–Li 0.2 mM EDTA, pH 7.4.
Differential permeability of the cations at both sides of the membrane
can give rise a transmembrane potential, which can then bemeasured
by means of the potential-sensitive probe DiSC3(5). The probe par-
tition is enhanced and its ﬂuorescence emission is self-quenched in
the presence of transmembrane electrochemical gradients. The effect
of MccJ25 I13W on the permeability of DPPC liposomes was studied
bymeasuring the ﬂuorescence emission of 0.5 μMDiSC3(5) added to a
1 mM phospholipid suspension, with excitation and emission wave-
lengths set at 622 and 677 nm, respectively.
3. Results
3.1. Peptide–membrane interaction
Studies on the interaction of liposomes with MccJ25 by intrinsic
ﬂuorescence spectroscopy were difﬁcult to carry out because the pri-
mary structure of the peptide has two tyrosine and two phenylalanine
residues but no tryptophan. As a consequence, the MccJ25 emission
spectrum showed only features of Tyr residues, with a maximum at
303 nm and low sensitivity to environmental changes [23,24]. A slight
decrease in the ﬂuorescence intensity at lowpeptide: lipid ratio (1:100)
was observed when the peptide was incubated with DPPC liposomes.
On the other hand, theﬂuidity ofDPPC liposomeswas slightly alteredbyFig. 2. Effect of addition of DPPC and DMPC liposomes on the ﬂuorescence emission spectra
27 ° C and titrated different amounts of DPPC (A) or DMPC (B) liposomes. Emission spectra w
addition. Peptide:lipid molar ratio were 1:0 (□), 1:20 (○), 1:100 (∇), 1:150 (Δ), and 1:200MccJ25 only at peptide/phospholipid ratios above 20. In order to study
the interaction of the peptide with model membranes in a more
sensitive system, we decided to obtain MccJ25 mutants in which some
of peptide amino acids were replaced by tryptophan.
Replacement of isoleucine13, which is located at the lasso region of
the molecule (Fig. 1), by tryptophan led to the formation of an
analogous, MccJ25 I13W, that could be puriﬁed by following the same
protocol used for MccJ25 and preserved both antimicrobial activity
(MIC=40 nM against S. enteritidis serovar Newport) and physico-
chemical properties, like similar retention time in analytic HPLC and
secondary structure, as assayed by infrared spectroscopy.
The variant peptide MccJ25 I13W showed a ﬂuorescence emission
maximum at 353 nm, indicating that the tryptophan residue is
exposed to aqueous solvent (Fig. 2) and that no peptide aggregation
occurred in the concentration range used in this work (0.5–10 μM).
By titrating a 2 μM aqueous solution of MccJ25 I13W with DPPC
liposomes at 27 °C, two notable effects on the emission ﬂuorescence
spectrum of the peptide were observed: amarked blue shift of emission
maximum, reaching a minimum value at 335 nm, and an increase in
emission intensity (Fig. 2A). The effect was dependent on the amount
of added lipid, reaching the maximum at 1:200 peptide:lipid molar
ratio. However, the addition of DMPC liposomes to 2 μM MccJ25
I13Wdid not produce either of these two effects (Fig. 2B). Since these
experiments were performed at 27 ° C, the physical state of the DMPC
was liquid crystal phase (TM DMPC=21 °C), whereas the physical
state of DPPC corresponded to gel phase (TM DPPC=41 ° C), sug-
gesting a preferential interaction of MccJ25 I13W with gel phase
membranes. However, in order to determine whether this effect
could be also be related to the difference in the chain length of the
phospholipids, ﬂuorescence spectra of the peptide were measured in
the presence of the same liposomes but at 12 °C, so that both
membrane systems were under their TM. As can be seen in Fig. 3,
when the experiments were performed with DPPC and DMPC lipo-
somes in the gel phase, the ﬂuorescence spectra of MccJ25 I13W
underwent similar changes, although the blue shift of the emission
spectra and the increase in intensityweremore pronounced for DPPC
membranes (Fig. 3A) respective to DMPC liposomes (Fig. 3B) at the
same peptide:phospholipid ratio. On the contrary, measurements
carried out at 50 °C in (both kind of liposomes found in liquid crystal
phase) no modiﬁcations of the ﬂuorescence spectra were obtained
(results not shown).of MccJ25I13W. MccJ25I13W (2.5 μM) dissolved in aqueous solution was incubated at
ere recorded by excitation at 288 nm after incubating 5 min between successive vesicle
(◊) for DPPC liposomes and 1:0 (□), 1:100 (○) and 1:200 (Δ) for DMPC liposomes.
Fig. 3. Effect of DPPC and DMPC liposomes on the ﬂuorescence emission spectra of MccJ25I13W. MccJ25I13W (2.5 μM) dissolved in aqueous solution was incubated at 12 °C and
titrated with different amounts of DPPC (A) or DMPC (B) liposomes. Emission spectra were recorded by excitation at 288 nm. Peptide:lipid molar ratio were 1:0 (□), 1:50 (Δ), 1:100
(○) and 1:200 (∇).
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water soluble quenchers
In order to determine whether the observed blue shift in emission
spectra ofMCCJ25 I13W in the presence of gel phase liposomeswas due
speciﬁcally to the partition of the peptide into the lipid bilayer,
experiments were performed by measuring the accessibility of the
Trp-containing peptide to the water soluble quencher Cesium chloride.
Addition of CsCl decreased the ﬂuorescence emission of MccJ25
I13W in the absence of membranes, conﬁrming that the Trp residue
was exposed to the solvent at peptide concentrations of 2 μM
(Fig. 4A), in accordance with the ﬂuorescence emission maxima at
353 nm of the peptide dissolved in buffer. As a comparison, the
quenching of NATA by CsCl yielded a higher value of KSV than MccJ25
I13W in buffer (2.37 vs. 1.67 M−1, respectively, Table 1), indicating
that, although solvent exposed, the tryptophan residue becomes less
accessible to the quencher when in the peptide structure, probablyFig. 4. Quenching of MccJ25 I13W (A) andMccJ25 (B) ﬂuorescence emission by cesium. Samp
the absence (□) and in the presence of DPPC (○) or DMPC (Δ) at a peptide:phospholipid
Fluorescence emission of MccJ25 and MccJ25I13W was determined at 303 or 353 nm by ex
3 μM ﬁnal concentration and ﬂuorescence emission at 353 nm when excited at 288 nm was
Stern–Volmer plots and represent the means±SD of three independents experiments.because of its lower diffusion coefﬁcient respective to the tryptophan
derivative NATA.
The results shown as Stern–Volmer graphs in Fig. 4 also indicated
that cesium was as effective in quenching the intrinsic ﬂuorescence
emission of MccJ25 I13Wwhen the experiment was performed in the
presence or in the absence of DMPC liposomes (Fig. 4A). However,
when carried out in the presence of DPPC liposomes at 27 °C, a de-
crease in the peptide ﬂuorescence quenching efﬁciency was observed,
indicating that the Trp residue of MccJ25 I13W was in a location
inaccessible to the quencher when liposomes in gel phase were
present in the medium (Fig. 4A). Quenching experiments with the
native MccJ25 gave the same results, indicating that the change of Ile
for Trp did not alter the characteristic of the peptide and its interaction
with lipid bilayers (Fig. 4B).
Table 1 reports the Stern–Volmer constants calculated according
to the slopes of the corresponding plots and highlights more precisely
the results mentioned above.les of MccJ25I13W (2.5 μM) orMccJ25 (10 μM) dissolved in phosphate buffer pH 7.4, in
molar ratio of 1:200, were incubated at 27 °C with different concentrations of CsCl.
citing at 277 or 288 nm, respectively. The tryptophan derivative NATA (A) was used at
recorded in the presence of increasing amounts of CsCl (∇). The results are shown as
Table 1
Stern–Volmer constants of intrinsic peptide ﬂuorescence quenching by Cs.
KSV (M−1)
MccJ25 I13W MccJ25 N-acetyl-tryptophanamide
Buffer 1.67±0.04 1.44±0.04 2.37±0.06
DPPC 0.54±0.09 0.38±0.09
DMPC 1.62±0.12 1.50±0.12
The Stern–Volmer constants were obtained from the slope of F0/F at increasing
concentrations of CsCl (Fig. 4). The results are themeanof three independent experiments.
Table 2
Partition coefﬁcient and cooperative parameter of the interaction of MccJ25 I13W with
liposomes.
Kp (M−1) n
DPPC 21 °C 5974 1.87
DPPC 12 °C 10558 2.22
DPPC:DPPS 7:3 21 °C 8385 1.79
The parameters were obtained from ﬁtting the MccJ25 I13W intrinsic ﬂuorescence
emission increase at 335 nm upon liposome titration to the equation described in
section 2.5.
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The increase in quantum yield of MccJ25 I13W in the presence of
gel phase membranes was employed to calculate the extent of
interaction with the bilayers. Partition coefﬁcients were calculated
bymeasuring the increase of peptide ﬂuorescence at 335 nm, which is
proportional to the amount of peptide that partitions from the aqueous
phase to the lipid bilayer. As shown in Fig. 5, theMccJ25 I13W binding
isotherm to DPPC liposomes in the gel phase was described by a
sigmoid function, suggesting a cooperative process, with a partition
coefﬁcient Kp of 5974 M−1 and a cooperativity coefﬁcient of 1.87.
When the experiment was made at 12 °C instead of 21 °C, the ﬂuo-
rescence increase reached a plateau at lower concentrations of lipids
(Fig. 5A), suggesting a higher afﬁnity for DPPC liposomes. This was
conﬁrmed by the higher partition coefﬁcient (Kp=10558 M−1) ob-
served in this condition (Table 2) and the increase in cooperativity
coefﬁcient.
The partition of MccJ25 I13W to DPPC liposomes was improved
by increasing the negative surface charge by adding 30% of DPPS
to liposomes (Kp=8385 M−1, Table 2). The presence of high ionic
strength in the medium did not modify the partition isotherms of
MccJ25 I13WtoDPPCneitherDPPC:DPPS7:3 liposomes, suggesting that
predominantly the order of the lipid bilayer rather than the negative
charge determines the microcin interaction with the membrane
(Fig. 5B).
3.4. Studies on the insertion of MccJ25 I13W into the bilayer
In order to determine the depth of insertion of MccJ25 I13W in the
lipid bilayer, intrinsic ﬂuorescence quenching of the peptide with
doxyl derivatives of stearic acid assayswas performed. These fatty acid
probes are modiﬁed with doxyl groups at speciﬁc positions along the
hydrocarbon chain. After being added to suspensions of liposomes,
these probes insert parallel to the fatty acid chains of phospholipids,
positioning the doxyl group at speciﬁc depths in the hydrophobicFig. 5. Binding isotherms of peptides to DPPC liposomes. MccJ25I13W (2 μM) dissolved in p
peptide ﬂuorescence emission at 335 nmwas determined by exciting at 288 nm. The parame
of MccJ25I13W to DPPC liposomes at 21 °C (□) and 12 °C (○). (B) Binding isotherms of Mcc
mixture of DPPC:DPPS, 7:3 (○) and DPPC:DPPS 7:3 in the presence of 1 M NaCl (∇).region of the membrane and quenching the intrinsic ﬂuorescence of
the peptides. The efﬁciency of the ﬂuorescence quenching is greater
the closer the doxyl groups and the peptide are located.
The Stern–Volmer plots shown in Fig. 6A indicate that both 5-DS and
16-DS quenched the intrinsic ﬂuorescence (335 nm) of the peptide
when preincubated with DPPC liposomes in a peptide to phospholipd
molar ratio of 1:200 at 27 °C. Also, the results showed that the 5-DSwas
a signiﬁcantly more effective quencher than 16-DS (KSV=11.41 M−1
and 8.03 M−1 for 5-DS and 16-DS, respectively, Table 3), indicating that
the Trp residue of MccJ25 I13W was located preferentially at the
interfacial zone. On the other hand, no quenching was observed with
either the 5-DS (Fig. 6B) or 16-DS probe (Fig. 6C)when the peptidewas
incubated at 27 °C in the presence of liposomesmade of DMPC at 1:200
peptide to lipidmolar ratio, conﬁrming that the peptide did not insert in
liquid crystal state PC bilayers.
3.5. Membrane perturbation induced by MccJ25 I13W: Permeability
assays
In order to determine whether the interaction of MccJ25 I13W
with DPPC liposomes produced any changes in the properties of the
bilayer, we decided to perform an assay for studying the DPPC per-
meability to small ions. In this way, phospholipid vesicles were loaded
with lithium sulfate and then suspended in isotonic buffer containing
sodium sulfate. The hydrophobic cationic ﬂuorescent probe DiSC3(5),
which decreases its ﬂuorescence emission intensity in the presence of
bilayers polarized transmembrane electrochemical gradients, was
used in order to evaluate differential ionic permeability.
The ﬂuorescence emission of DiSC3(5) in the presence of loaded
liposomes as a function of time is depicted in Fig. 7. It was shown that
MccJ25 I13W inducedmembrane polarization when added to the DPPC
liposomes suspension at 21 °C, this effect being proportional to the
actual peptide concentration used in the experiment (Fig. 7A). In ad-
dition, a signiﬁcantly lower degree of membrane polarization washosphate buffer pH 7.4 was incubated with increasing concentrations of liposomes. The
ter I335 nm was calculated as described in Materials and methods. (A) Binding isotherms
J25I13W at 21 °C to DPPC liposomes alone (□), DPPC in the presence of 1 M NaCl (Δ), a
Fig. 6. Analysis of the interaction depth ofMccJ25I13Wwith liposomes. A suspension of DPPC liposomes (0.4 mM) andMccJ25I13W (2 μM) in phosphate buffer pH 7.4was incubated
at 27 °C with increasing concentration of 5-doxyl (□) or 16-Doxyl (○) of stearic acid. Fluorescence emission of MccJ25I13W at 335 nm was determined by exciting at 288 nm. The
results are the means±SD of three experiments and shown as Stern–Volmer plots (A). The effect of 5-doxyl (B) and 16-doxyl (C) quenchers on the ﬂuorescence emission spectra of
MccJ25 I13W in the presence of DMPC liposomes at 27 °C (▼) is shown. Spectra of the peptide in buffer (○) and incubated with DMPC at 1:200 molar ratio (●) were determined by
exciting at 288 nm.
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positive control, 0.01% (p/v) Triton X100 was used. In this case, the
increase in the DiSC3(5) ﬂuorescence emission intensity indicated com-
plete transmembrane potential dissipation due to the lost ofmembrane
integrity.
4. Discussion
Biological membranes exhibit lipid and protein diffusional rates
typical of bilayer ﬂuid states. However, lateral heterogeneity is also
observed as a consequence of the natural properties of lipids and
proteins to segregate into domains of different composition and higher
degree of order [25–27]. Thus, certain enzymes were functionally
related to lipid rafts and an increasing number of peptides are being
reported to interact with ordered membranes [28,29]. The effects of
MccJ25 on biological membranes involve oxygen consumption
cessation, deleterious oxidative species generation and respiratory
chain enzymes inhibition, and were observed in bacteria and
mitochondria as well [12,16,30,31]. However, in bacteria these effects
seem to be a consequence of another primary target, because no re-
vertant mutant could be naturally isolated. This primary target could
be the phospholipid bilayer, the locationwherein these processes take
place. Interestingly, the generation of reactive oxygen species at the
bacterial inner membrane can be induced by MccJ25 even though the
outer membrane transporter FhuA, which carry the microcin into the
bacterial cell, is inhibited [16]. This suggests that MccJ25 effects on
membrane occur simultaneously with the protein mediated entrance
of the peptide to cell for RNA polymerase targeting.
The mutant peptide MccJ25 I13W was shown to be a membrane-
active peptide as demonstrated by ﬂuorescence spectroscopy experi-
ments in this work. Both the blue shift of the emission spectra and the
increased quantum yield of tryptophan from MccJ25 I13W, observed
only when gel phase membranes were added, strongly suggest aTable 3
Stern–Volmer constants of intrinsic peptide ﬂuorescence quenching by 5-doxyl and 16-
doxyl stearic acid.
Quencher KSV (M−1)
5-DS 11.41±1.73
16-DS 8.03±0.82
The Stern–Volmer constants were obtained from the slope of F0/F at increasing
concentrations of doxyl-probes (Fig. 6). The results are the mean of three independent
experiments.selective interaction of the peptide with membranes with high order
degree.
The inhibition of the effect of water-soluble quenchers on the
intrinsic ﬂuorescence of MccJ25 I13W observed upon peptide
incubation with DPPC liposomes at 27 °C conﬁrmed that this mem-
brane interaction was indeed a partitioning of MccJ25 I13W from the
aqueous to the membrane hydrophobic phase. Experiments carried
out with doxyl-labeled fatty acids showed that MccJ25 I13W
penetrated into the lipid bilayer but was preferentially located near
the interfacial zone of the membrane, since 5-DS was a more efﬁcient
quencher than 16-DS.
The position 13 of MccJ25 sequence lies at the extreme of the lasso
structure of the peptide and was chosen for tryptophan mutation
because, as previously reported, small if any perturbation in the
interaction with bacterial membranes was observed for variants of
MccJ25 involving this position [16,32]. Taking into account the
interfacial preference of Trp13 in the hydrophobic lasso as indicated
by the doxyl quenching experiments and that the only charge of the
molecule belongs to the carboxyl group of the C-terminal Gly21, which
would also prefer to locate near the polar region of themembrane, the
peptide would lay in a ﬂat position along the interfacial region of the
bilayer.
Liquid crystal phase membranes did not produce a blue shift of
tryptophan ﬂuorescence of MccJ25 I13W nor inhibition of ﬂuores-
cence quenching by cesium. Also, the probes 5-DS and 16-DS did not
quench peptide ﬂuorescence in the presence of liquid crystal DMPC,
strongly supporting the lack of interaction of MccJ25 I13W with
disordered membranes.
The sigmoid dependence of the partition of MccJ25 I13W to DPPC
liposomes in gel phase differs from the behavior observed with other
peptides. The partition constant obtained forMccJ25 I13Wwas almost
an order of magnitude lower compared with those reported for
nystatin [20], melittin [33], cecropin [34] and equinatoxin [35]. Pre-
vious partition models were developed in response to the experi-
mental data with polycationic peptides, which are concentrated on
the surface of negatively charged membranes and which diffuse into
the interface ormore hydrophobic regions until repulsive electrostatic
forces between peptide molecules exceed the attraction to the mem-
brane [33], giving rise to hyperbolic partition curves. Also, changes in
the peptide location at the membrane or the aggregation state as a
function of the peptide/phospholipid molar ratio would give rise to
deviation of the commonly observed hyperbolic partition curves
[36,37]. Because the MccJ25 I13Wmolecule contains mostly nonpolar
Fig. 7. Effect of MccJ25 on the permeability of DPPC liposomes. DPPC liposomes loaded with Li2SO4 and suspended in a buffer containing Na2SO4 were incubated with the ﬂuorescent
probe DiSC3(5). The timed evolution of ﬂuorescence emission of DiSC3(5) was recorded at 677 nm by exciting at 622 nm. (A) At the indicated time (*) MccJ25 5 μM (□) or 10 μM (○)
was added. (B) The effect of 10 μMMccJ25 was studied at 21 °C (□) and 55 °C (○). As a positive control of gradient dissipation, Triton X-100 was added at the speciﬁed times (**).
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conformational changes that promote the interaction with the bilayer,
the partition of the peptide to the membrane would be driven pri-
marily by its hydrophobic character. On the other hand, the sigmoidal
behavior of the peptide partition to membrane suggests that MccJ25
I13W induces changes in the bilayer which increase its afﬁnity to the
membrane.
According to previous studies, MccJ25 would not affect signiﬁcantly
the membrane integrity and liposomes did not show changes in the
permeability to large molecular weight substrates upon peptide
membrane interaction [19]. Our results, however, showed that MccJ25
I13Winduces alterations in thepermeability of DPPCbilayer causing the
loss of small ions. This effect, as expected,washigher in gel phase than in
liquid crystalline phase vesicles. Furthermore, there was no evidence of
decrease in turbidity and loss of high molecular weight molecules (not
shown), suggesting no alteration of the bilayer integrity by a detergent-
like action or the formation of pores, respectively.
It was postulated that packing defects of phospholipids in gel
phasemembrane give rise to the passage across the bilayer of ions and
small polar molecules [38]. Thus, the sigmoidal behavior of the
peptide partition and the increased permeability of the bilayer to
small ions upon MccJ25 I13W membrane interaction suggest that the
peptide would cause a disturbance in the gel phase membrane, such
as packing defects that could also facilitate the entry of more peptide
molecules.
Although all experiments shown in this study were performed
using PC liposomes as a model of zwiterionic membrane, no effect of
high ionic strength on the partition of the MccJ25 I13W to the
membrane was found, indicating that mainly hydrophobic forces
modulate the interaction of peptide with the bilayer. This observation
is an important difference to with the case of many cationic antibiotic
peptides where the electrostatic attraction with the negative
phospholipids plays an almost exclusive role. Here, the presence of
phospholipids with negative charges at the bilayer, although slightly
increasing the peptide afﬁnity, does not point to the surface charge of
this phospholipid but toward the high TM and high hydrocarbon chain
order observed for DPPS at 27 °C as the parameters that drive the
interaction of the peptide with this membrane. Although these results
do not allow us to determine themechanism of action of MccJ25 at the
membrane level, we may conclude that the degree of order of the
bilayer would determine the selectivity and afﬁnity of MccJ25 I13W
toward the membrane rather than the nature and charge of the
phospholipids polar head. Experiments are being carried out now in
our laboratory to elucidate the precise mechanism of action of MccJ25
on biological membrane.Acknowledgements
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